Aardvark Therapeutics Soars 15% on Bank of America's Price Target Hike

Generado por agente de IAAinvest Movers Radar
viernes, 28 de marzo de 2025, 5:34 am ET1 min de lectura
AARD--

On March 28, 2025, Aardvark's stock price surged to $12.36 in pre-market trading, indicating a strong bullish sentiment among investors.

Bank of America has raised its price target for Aardvark TherapeuticsAARD-- from $22 to $26, maintaining a Buy rating. This move reflects the bank's confidence in the company's future performance and potential for growth.

This positive outlook from a major financial institution is likely to bolster investor confidence in AardvarkAARD-- Therapeutics, potentially driving further stock price appreciation.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios